N-Acetylimidazolidinone → HCID 71252331, compound

HRID 2411753Notes

Reaction equation

HRID 2411753 reaction equation
[C:1]([N:4]1[CH2:8][CH2:7][NH:6][C:5]1=[O:9])(=[O:3])[CH3:2].Br[C:11]1[CH:12]=[CH:13][C:14]([C:17]([N:19]2[CH2:24][CH2:23][N:22]([C:25]3[CH:30]=[CH:29][C:28]([CH3:31])=[CH:27][C:26]=3[CH3:32])[CH2:21][CH2:20]2)=[O:18])=[N:15][CH:16]=1>>[C:1]([N:4]1[CH2:8][CH2:7][N:6]([C:11]2[CH:16]=[N:15][C:14]([C:17]([N:19]3[CH2:20][CH2:21][N:22]([C:25]4[CH:30]=[CH:29][C:28]([CH3:31])=[CH:27][C:26]=4[CH3:32])[CH2:23][CH2:24]3)=[O:18])=[CH:13][CH:12]=2)[C:5]1=[O:9])(=[O:3])[CH3:2]

Participants

3

Procedure

Using 1-acetyl-2-imidazolidinone (128 mg) and (5-bromopyridin-2-yl)[4-(2,4-dimethylphenyl)piperazin-1-yl]methanone (374 mg) described in Preparation Example 137 and by the reaction and treatment in the same manner as in Example 1, the title compound (155 mg) was obtained.

Workup

  1. customdescribed in Preparation Example 137 and by the reaction and treatment in the same manner as in Example 1

Sources & evidence

ORD record
ord-8759d70e940e4e1f8855de88af3950db
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…